exceed 20% (Revised) To : The President The Stock Exchange of Thailand Bangkok Chain Hospital Public Company Limited (the “Company”) would like to report the operating results of the Company and its
, stood at Baht 0.35 million, as against 3% of said NTA of Baht 35.43 million. Accordingly, said transaction volume warranted the Company to seek approval from The Board of Directors and to report said
ขยายเวลาการส่งรายงานการก ากบัดูแลการปฏิบติังานประจ าปี (annual compliance report) ต่อส านกังาน จาก 1 เดือน เป็น 2 เดือนนบัแต่วนัส้ินปีปฏิทิน เหตุผล เพื่อให้ compliance มีเวลาเพียงพอในการจดัท าสรุปผลการ
(Thailand) Public Company Limited (“Company”), hereby report the resolutions passed the related transactions with the related companies (Details as attachment) at the meeting of the Board of Directors No.10
2019 To : The President The Stock Exchange of Thailand Bangkok Chain Hospital Public Company Limited (the “Company”) would like to report the operating results of the Company and its subsidiaries
November 2019, approving the audited consolidated financial statements for Quarter 3 of 2019 ending on 30 September 2019. The Company would like to report factors that affect the financial performance of the
762,160,000 baht (according to the appraisal report of Sasirachada Company Limited on 1 October 2019.) 6. Source of Funding Internal Working Capital 7. Valuation of the investment Par value of ordinary shares
Province and expected to open in 2021. With the value of land and buildings Assessed by the valuation method in the amount of 762,160,000 baht (according to the appraisal report of Sasirachada Company
the date of this transaction, it will make the total transaction size equal to 9.20 percent of the Company’s total asset value. The transaction size does not fall within the scope to report information
report of Sasirachada Company Limited on 1 October 2019.) 6. Source of Funding Internal Working Capital and received a refund of capital from a subsidiary company which is in the process of liquidation 7